Clinical Efficacy And Safety Of An Abl Specific Tyrosine Kinase Inhibitor As Targeted Therapy For Chronic Myelogenous Leukemia.Bj Druker,M Talpaz, D Resta,B Peng,E Buchdunger,J Ford,Cl SawyersBLOOD(1999)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要